Equities

Charlotte's Web Holdings Inc

Charlotte's Web Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.20
  • Today's Change0.01 / 5.26%
  • Shares traded17.56k
  • 1 Year change-68.25%
  • Beta1.9147
Data delayed at least 15 minutes, as of Sep 20 2024 20:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments486719
Total Receivables, Net2.332.4216
Total Inventory222752
Prepaid expenses2.812.618.10
Other current assets, total3.674.81--
Total current assets7810496
Property, plant & equipment, net424657
Goodwill, net----0
Intangibles, net18292.84
Long term investments11----
Note receivable - long term--01.04
Other long term assets3.319.3915
Total assets153188172
LIABILITIES
Accounts payable2.864.025.05
Accrued expenses119.219.57
Notes payable/short-term debt000
Current portion long-term debt/capital leases--0.455.55
Other current liabilities, total9.857.76--
Total current liabilities242120
Total long term debt433721
Total debt433826
Deferred income tax------
Minority interest------
Other liabilities, total31510.01
Total liabilities9711041
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital327325319
Retained earnings (accumulated deficit)(272)(248)(189)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity5678130
Total liabilities & shareholders' equity153188172
Total common shares outstanding154152145
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.